# OnCo record paper-mpact-nab-paclitaxel-gemcitabine-nejm-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mpact-nab-paclitaxel-gemcitabine-nejm-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mpact-nab-paclitaxel-gemcitabine-nejm-2013" ;
  schema:name "MPACT (Von Hoff 2013): nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer"@en ;
  schema:description "Adding albumin-bound paclitaxel to gemcitabine prolonged survival in metastatic pancreatic cancer in a large international trial, giving patients who are not fit enough for FOLFIRINOX a second effective first-line option."@en ;
  schema:url <https://onco.cc/key-papers/paper-mpact-nab-paclitaxel-gemcitabine-nejm-2013/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1304369>, <https://clinicaltrials.gov/study/NCT00844649> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1304369> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Von Hoff DD, Ervin T, Arena FP, et al." ;
  onco:related <https://onco.cc/key-papers/paper-conroy-folfirinox-pancreatic-nejm-2011/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:terms <https://onco.cc/terms/os/>, <https://onco.cc/terms/pfs/> ;
  onco:people <https://onco.cc/people/daniel-von-hoff/> .